The Journal of Immunology, Vol 144, Issue 2 432-439, Copyright © 1990 by American Association of Immunologists

ARTICLES

Transforming growth factor beta 1 has differential effects on B cell proliferation and activation antigen expression

D Cross and JC Cambier
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.

There is accumulating evidence that TGF beta 1 is an important immunoregulatory molecule. Here we report evidence that TGF beta 1 has potent effects on murine B cells. It is profoundly inhibitory to the proliferation of quiescent B cells activated in model systems using both thymus-independent and thymus-dependent stimuli and arrests cells predominantly at the G1 cell-cycle stage. It also blocks the proliferation of B cell blasts, with a similar accumulation at stage G1. In parallel with this antiproliferative effect, TGF beta 1 inhibits induction of the expression of a series of "activation Ag" including transferrin receptor, RL388, and Ly-6, in mitogen-stimulated B cells. It also inhibits the induction of Ly-6 expression by IL-4, a nonmitogenic stimulus. In contrast to these negative influences, TGF beta 1 induces modestly increased expression of MHC class II Ag in quiescent B cells, and more marked increases in both B cell blasts and mitogen-stimulated cells. We speculate that in the appropriate context TGF beta 1 may be a cytokine that promotes productive B cell-Th cell interaction.

This article has been cited by other articles:

				J. Roes, B. K. Choi, and B. B. Cazac Redirection of B cell responsiveness by transforming growth factor {beta} receptor PNAS, June 10, 2003; 100(12): 7241 - 7246. [Abstract] [Full Text] [PDF]

				A. Mouzaki, M. Theodoropoulou, I. Gianakopoulos, V. Vlaha, M.-C. Kyrtsonis, and A. Maniatis Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis Blood, August 13, 2002; 100(5): 1774 - 1779. [Abstract] [Full Text] [PDF]

				E. K. Deenick, J. Hasbold, and P. D. Hodgkin Switching to IgG3, IgG2b, and IgA Is Division Linked and Independent, Revealing a Stochastic Framework for Describing Differentiation J. Immunol., November 1, 1999; 163(9): 4707 - 4714. [Abstract] [Full Text] [PDF]

				K. Lingnau, P. Hoehn, S. Kerdine, S. Koelsch, C. Neudoerfl, N. Palm, E. Ruede, and E. Schmitt IL-4 in Combination with TGF-{beta} Favors an Alternative Pathway of Th1 Development Independent of IL-12 J. Immunol., November 1, 1998; 161(9): 4709 - 4718. [Abstract] [Full Text] [PDF]

				M. C. Horne, K. L. Donaldson, G. L. Goolsby, D. Tran, M. Mulheisen, J. W. Hell, and A. F. Wahl Cyclin G2 Is Up-regulated during Growth Inhibition and B Cell Antigen Receptor-mediated Cell Cycle Arrest J. Biol. Chem., May 9, 1997; 272(19): 12650 - 12661. [Abstract] [Full Text] [PDF]

				E. Raz, J. Dudler, M. Lotz, S.M. Baird, C.C. Berry, R.A. Eisenberg, and D.A. Carson Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery Lupus, August 1, 1995; 4(4): 286 - 292. [Abstract] [PDF]